Pharmacy Law & Ethics & Pharmaceutical Jurisprudence | Pharmacy Law & Ethics DPEE Test Noteskarts

Pharmacy Law & Ethics & Pharmaceutical Jurisprudence | Pharmacy Law & Ethics DPEE Test

This test is Improve for Pharmacy exam like Diploma in Pharmacy exit exam MCQs (DPEE), GPAT, & other competitive exam. Pharmacy Law & Ethics Class Test | Pharmacy Law & Ethics DPEE Test

365

1 / 50

1. The schedule in Drug and Cosmetics Act that deals with requirement and guidelines of clinical trial, import and manufacture of new drug is

a. Schedule M

b. Schedule Y

c. Schedule O

d. Schedule F

2 / 50

2. Kala jadu or Kavach comes under

a. Schedule L

b. Schedule J

c. Schedule P

d. Schedule K

3 / 50

3. Pro-forma for sending memorandum is included in which schedule?

a. D

b. Q

c. FF

d. A

4 / 50

4. If blood group is “AB” then colour label used is

a. White

b. Blue

c. Red

d. Yellow

5 / 50

5. For licence granted to sell by retail drugs, specified in schedule C and C(1) drugs from no. require is

a. 21B

b. 20

c. 20B

d. 21

6 / 50

6. As per D & C Act “Schedule FF” is related with

a. Ophthalmic preparation

b. Skin cosmetic preparation

c. Ointment formulation

d. Parenteral preparation

7 / 50

7. Schedule J is related to

a. List of disease and ailments which drug cannot claim.

b. Pack sizes of drugs.

c. Curable disease

d. GMP

8 / 50

8. DTAB has ———————– ex officio members

a. Five

b. Four

c. Eight

d. Six

9 / 50

9. List of drugs which should be used by patient under medical supervision is covered under………..as per D & C Act.

a. Schedule I

b. Schedule H

c. Schedule J

d. Schedule G

10 / 50

10. Hatch Waxman Act is related to

a. Dangerous drugs Act

b. Banned drugs

c. Spurious drugs Act

d. Over the counter drugs

11 / 50

11. Aspirin sodium comes under

a. Schedule Y

b. Schedule J

c. Schedule H

d. Schedule G

12 / 50

12. Grant of licence to manufacture a drug requires.

a. Form 27

b. Form 24

c. Form 26

d. Form 25

13 / 50

13. Pharmacy Council of India (PCI) is reconstituted:

a. Every 6 year

b. Every 2 year

c. Every 3 year

d. Every 5 year

14 / 50

14. In Phase-2 trial following number of patient should be studied

a. 1-10 patients

b. 500 patients

c. 10-12 patients

d. 100 patients

15 / 50

15. Post marketing surveillance comes under clinical trial

a. Phase I

b. Phase II

c. Phase III

d. Phase V

16 / 50

16. In 1954 one of the following act is passed

a. The Medical Termination of pregnancy Act

b. Drug and magic Remedies Act

c. Narcotic and psychotropic substance Act

d. Poisonous Act.

17 / 50

17. If drug is so colored, coated or polished that damage its therapeutic value or it is made to appear of better or greater therapeutic value than it really is known as

a. Adulterated Drug

b. Misbranded Drug

c. True Drug

d. Spurious Drug

18 / 50

18. TGA is regulatory agency of………….

a. Zimbabwe

b. India

c. Australia

d. Denmark

19 / 50

19. Standard for mechanical contraceptive comes under Schedule ………………as per D & C Act

a. R1

b. O

c. S

d. R

20 / 50

20. In State Pharmacy Council all following are ex officio members except.

a. The officer in charge of drugs control organization

b. Chief Administrator medical officer of state

c. President of India

d. Government Analyst

21 / 50

21. Example of Schedule G drug is

a. Enalapril

b. Barbital

c. Metformin

d. Cefuroxime

22 / 50

22. Injection syringe and needles are covered under

a. Schedule Q

b. Schedule P

c. Schedule B

d. Schedule A

23 / 50

23. Pharmacy Council of India contain comprises…….. Members (s) from AICTE and UGC.

a. 1

b. 3

c. 4

d. 2

24 / 50

24. Which of the following is prohibited to be imported?

a. Ayurvedic drugs

b. Schedule ‘C’ ‘G’ drugs

c. Toilet preparations

d. Misbranded drugs

25 / 50

25. Coca, opium and hemp come under:

a. Insecticide Act

b. Dangerous Drug Act

c. Spurious Drug Act

d. Poisons Act

26 / 50

26. As per D and C act schedule T stated about

a. Requirements of factory premises for the manufacture of Medical device

b. Requirements of factory premises for the manufacturer of Homeopathy drugs

c. Requirements of factory premises for the manufacturer of Ayurveda, Sidhha and Unani drugs

d. Requirements of factory premises for the manufacturer of Allopathy drugs

27 / 50

27. Dettol comes under

a. Schedule P

b. Schedule Q

c. Schedule O

d. Schedule N

28 / 50

28. MCC is regulatory agency of ……………

a. UK

b. South Africa

c. Brazil

d. Denmark

29 / 50

29. One of the following is/all ex officio member(s) of State Pharmacy Council

a. Assistant drug controller

b. All

c. Chief administrative medical officer of the state

d. Chief pharmacist of government hospital

30 / 50

30. List of coal tar colours permitted to be used in cosmetics is covered under.

a. Schedule O

b. Schedule R

c. Schedule P

d. Schedule Q

31 / 50

31. State Pharmacy Council should have the following number of elected members.

a. Seven

b. Five

c. Six

d. Nine

32 / 50

32. List of drugs whole import, manufacture and sale, labeling and packaging are governed by special provisions are included in schedule.

a. H

b. K

c. G

d. X

33 / 50

33. Schedule N states

a. Requirement of factory premises and hygienic condition to complied

b. List of minimum equipment for efficient running of pharmacy

c. List of minimum equipment required for manufacturing of drug.

d. Standard for cosmetics

34 / 50

34. As per D and C Act “Schedule N” is related with

a. Area required to open wholesale drug store

b. Area for opening retail pharmacy

c. List of maximum equipments for efficiently running pharmacy

d. List of minimum equipments for efficiently running pharmacy

35 / 50

35. Biological and Biotechnological products are included in schedule.

a. A

b. C and C1

c. B

d. X

36 / 50

36. For schedule X drug use of Human beings special labeling requirement require is

a. Symbol H displayed on right top corner of the label.

b. Symbol X given in red

c. Symbol N is red displayed on left top corner of the label

d. Symbol N displayed on left top corner of the label.

37 / 50

37. MHRA is regulatory agency of ……….....

a. UK

b. South Africa

c. Denmark

d. Brazil

38 / 50

38. Schedule C is related to

a. List of Allopathic product

b. List of Biological and Immunological product

c. List of Ayurvedic product

d. List of Homeopathy product

39 / 50

39. Schedule…………… of Drugs and Cosmetics Act in Cludes requirements and guidelines on clinical trials for import and manufacturing of new drugs.

a. X

b. W

c. V

d. Y

40 / 50

40. Schedule D as per D & C Act is concerned with

a. Disease or ailments which a drug may not purport to prevent or cure

b. Requirements of factory premises

c. List of drug exempted from the provision of import of drugs

d. List of prescription drugs

41 / 50

41. Schedule X of Drugs and Cosmetics Act comprises

a. List of incurable diseases

b. List of generic drugs

c. None of the above

d. Guidelines for clinical Trials

42 / 50

42. Patent Act is established in

a. 1948

b. 1970

c. 1940

d. 1919

43 / 50

43. Pack size of drug is covered under

a. Schedule P1

b. Schedule O

c. Schedule R

d. Schedule P

44 / 50

44. The Education Regulation (ER) is published in official gazette by

a. Ministry of Education

b. President, Pharmacy Council of India

c. Central Government

d. Drug Controller

45 / 50

45. Drug and Magic Remedies Act is enacted in

a. 1948

b. 1985

c. 1919

d. 1954

46 / 50

46. As per schedule P Carbenicillin Sodium Powder Should be Stored in/at

a. A cool place

b. A Cold place

c. Temperature not exceeding 5°C

d. Well closed container, protect from light, in cool place, protect from light

47 / 50

47. Insulin injection according to schedule P is should be stored

a. At the Temperature 2°C to 8°C and it must not allow to freeze

b. At temperature which not exceed 5°C

c. In cold place

d. At temperature which not exceed 20°C

48 / 50

48. The first edition of India Pharmacopoeia was published in the year :

a. 1955

b. 1985

c. 1940

d. 1950

49 / 50

49. Purpose of Phase-3 trial is

a. Efficacy and Safety of drug in longer number of patients (500 patients)

b. Long time adverse effects aster marketing drug

c. Determine Possible therapeutic uses, Effective doses range

d. To determine maximum tolerated dose in humans, Pharmacodynamics effects, Adverse effect.

50 / 50

50. For parenteral preparation in glass containers minimum area required is

a. 150 square meters

b. 500 square meters

c. 250 square meters

d. 400 square meters

Your score is

The average score is 38%